Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study will be to determine if blockade of endothelin 1 signalling via
endothelin receptor A using ambrisentan or dual blockade (A&B) via bosentan can provide
protection against methacholine induced bronchoconstriction in asthma.